Non-Invasive Prenatal Testing Market Survey Report by Clinical Expert, forecast 2021-2026

Global Non-Invasive Prenatal Testing Market Size and Forecast to 2021 – 2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide a detailed description of the value chain and its distributor analysis. This Market study provides comprehend Non-Invasive Prenatal Testing data that enhances the understanding, scope, and application of this report.

The study includes market share analysis and profiles of players such as BGI, CENTOGENE AG, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Illumina, Inc., Myriad Genetics, Inc., PerkinElmer Inc., Quest Diagnostics, GE Healthcare, Agilent Technologies, Inc..

Click here to get a free sample copy of the latest research on Non-Invasive Prenatal Testing market (Flat 25% Off):

https://www.marketinsightsreports.com/reports/05202907455/non-invasive-prenatal-testing-market-growth-trends-covid-19-impact-and-forecasts-2021-2026/inquiry?Mode=A28

The global Non-Invasive Prenatal Testing Market market was valued at approximately USD 1,490 million in 2020 and it is expected to reach USD 3,396 million by 2026, registering a CAGR of nearly 14.4% during the forecast period (2021-2026).

Market Trends:

Down Syndrome Segment Dominates the Non-Invasive Prenatal Testing Market

Down syndrome is a chromosomal disorder and also called trisomy 21, trisomy G, 47, XX,+21, and 47, XY,+21. It includes certain birth defects, learning problems, and facial features. A child with Down syndrome may also have heart defects and problems with vision and hearing. According to the Centers for Disease Control and Prevention 2019, down syndrome is the most common chromosomal condition diagnosed in the United States. Every year, about 6,000 babies born in the United States have Down syndrome. This means that Down syndrome occurs in about 1 out of every 700 babies.

NIPT offers several clinical benefits over existing prenatal screening tests, such as maternal serum screening (MSS). According to a 2019 article published by Stanislav Birko et.al for the screening of Down syndrome NIPT can be performed as early as nine?weeks of pregnancy, holds no risk of miscarriage, and is able to detect the presence of Down syndrome, (trisomy 21) with high sensitivity (99.9%) and specificity (98%).

Noninvasive prenatal testing (NIPT) consists of analyzing cell-free DNA (cfDNA) circulating in the maternal blood in order to detect Down's syndrome.? With the successful introduction of noninvasive prenatal testing (NIPT) for Down syndrome into routine prenatal care, it is important to understand the risks, benefits, and limitations in order to guide patients in making an informed decision. As a result, the demand for these technologies has increased and is also being adopted in many developing countries., which may drive the segment growth.

Market Segmentation:

By Types:

High & Average Risk
Low Risk

By Applications:

0-12 Weeks
13-24 Weeks
25-36 Weeks

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/05202907455/non-invasive-prenatal-testing-market-growth-trends-covid-19-impact-and-forecasts-2021-2026?Mode=A28

Regional Analysis:

North America Dominates the Global Non-Invasive Prenatal Testing Market

North America holds a leading position in the Non-Invasive Prenatal Testing market during the forecast period. High preterm birth rate, maternal mortality rate, and rising incidences of chromosomal abnormalities will increase the adoption and demand for tests in this region.

According to Trisomy 18 Foundation, Edwards syndrome (Trisomy 18) error occurs in about 1 out of every 2500 pregnancies in the United States and 1 in 6000 live births. North America accommodates several major companies working on fetal and neonatal care from around the world, with direct distribution channels and third-party services for distribution in relation to medical/hospitals requirement. In Apr 2019, Progenity, Inc., announced the launch of the Resura Prenatal Test for Monogenic Disease. It is a commercially available, customizable, NIPT test for single-gene disorders.?

Furthermore, High rates of diagnosis, high adoption, and awareness among the people, and the introduction of new and technologically advanced tests are also contributing to the growth of the market in North America.

The study objectives of this report are:

To study and analyze the global Non-Invasive Prenatal Testing size (value and volume) by the company, key regions/countries, products and application, history data from 2020 to 2025, and forecast to 2026.
To understand the structure of Non-Invasive Prenatal Testing by identifying its various sub-segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Non-Invasive Prenatal Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
To analyze the Non-Invasive Prenatal Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Non-Invasive Prenatal Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Purchase full Report@:

https://www.marketinsightsreports.com/report/purchase/05202907455?mode=su?Mode=A28

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.